Butterfly Network (NYSE:BFLY) Posts Earnings Results, Beats Estimates By $0.01 EPS

Butterfly Network (NYSE:BFLY) posted its quarterly earnings results on Friday. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01, Zacks reports. Butterfly Network had a negative net margin of 129.25% and a negative return on equity of 42.68%. Butterfly Network updated its FY 2025 guidance to EPS.

Butterfly Network Trading Down 2.3 %

Shares of Butterfly Network stock traded down $0.09 on Friday, hitting $3.65. 6,571,611 shares of the company traded hands, compared to its average volume of 4,714,247. The company has a market cap of $776.61 million, a PE ratio of -7.90 and a beta of 2.47. The stock’s 50 day moving average price is $3.91 and its 200-day moving average price is $2.73. Butterfly Network has a 52 week low of $0.67 and a 52 week high of $4.98.

Insider Buying and Selling

In other news, insider Steve Cashman sold 164,079 shares of the company’s stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $3.06, for a total value of $502,081.74. Following the completion of the sale, the insider now owns 1,835,921 shares of the company’s stock, valued at approximately $5,617,918.26. This represents a 8.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Heather C. Getz sold 30,136 shares of Butterfly Network stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $3.06, for a total transaction of $92,216.16. Following the transaction, the chief financial officer now directly owns 2,669,333 shares in the company, valued at approximately $8,168,158.98. The trade was a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 27.28% of the stock is owned by insiders.

About Butterfly Network

Butterfly Network, Inc develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.